Pharmacological treatment of cognitive deficits in Alzheimer's disease

William Lam
Med J Aust 2002; 176 (6): . || doi: 10.5694/j.1326-5377.2002.tb04418.x
Published online: 18 March 2002

To the Editor: The review by Brodaty and colleagues1 on drug treatment of Alzheimer's disease provides a good, concise and balanced overview. However, Pfizer takes issue with some of the referenced safety data.

  • William Lam

  • Pfizer Pty Ltd, West Ryde, NSW.



remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.